Voyageur Pharmaceuticals (VM) News Today C$0.05 -0.01 (-9.09%) (As of 05:27 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartStock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 28, 2024 | finance.yahoo.comUpdate - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium ContrastMarch 13, 2024 | proactiveinvestors.comVoyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonJanuary 3, 2024 | morningstar.comVoyageur Pharmaceuticals Ltd VMDecember 21, 2023 | stockhouse.comVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsDecember 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)October 24, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)September 14, 2023 | stockhouse.comVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaSeptember 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaSeptember 7, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)June 20, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)May 31, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaMay 24, 2023 | finance.yahoo.comVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsMay 24, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonMay 10, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)May 4, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)May 2, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)April 29, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)April 28, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)April 26, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)April 22, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)April 21, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)April 14, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)April 8, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)April 6, 2023 | theglobeandmail.comClosing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)April 4, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imagingFebruary 14, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals preparing to launch sales of its first product in CanadaFebruary 10, 2023 | finance.yahoo.comVoyageur Pharmaceuticals Ltd. (VM.V)January 23, 2023 | proactiveinvestors.comVoyageur Pharmaceuticals completes second and final closing of its private placement for gross proceeds of $1,019,953.53December 8, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals launches SmoothX barium contrast media in CanadaDecember 5, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals issues deferred share units to directors under equity incentive compensation planDecember 3, 2022 | yahoo.comVoyageur Pharmaceuticals Ltd. Announces Equity Incentive CompensationNovember 1, 2022 | proactiveinvestors.comVoyageur Pharmaceuticals completes design for Alberta's first carbon-neutral pharmaceutical facilityOctober 31, 2022 | finance.yahoo.comVoyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for CustomersAugust 21, 2022 | reuters.comVoyageur Pharmaceuticals LtdMay 31, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private PlacementMay 10, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and DebtFebruary 24, 2022 | stockhouse.comVoyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment ReportJanuary 30, 2022 | stockhouse.comVoyageur Pharmaceuticals Ltd VYYRFDecember 6, 2021 | stockhouse.comVoyageur Pharmaceuticals Provides Update on PEA Progress & Takes a Major Step Towards Production Start UpSeptember 15, 2021 | benzinga.comVoyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading PhysiciansAugust 12, 2021 | stockhouse.comVoyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here VM Media Mentions By Week VM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VM News Sentiment▼0.000.62▲Average Medical News Sentiment VM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VM Articles This Week▼00▲VM Articles Average Week Get Voyageur Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MediPharm Labs News Today Decibel Cannabis News Today Willow Biosciences News Today Medicure News Today Valeo Pharma News Today Crescita Therapeutics News Today Indiva News Today Entourage Health News Today Aequus Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:VM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyageur Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyageur Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
